Clinical Efficacy Evaluation Methods of New TCM Drugs Used for Certain Syndromes

Ruijin Qiu,Xiaoyu Zhang,Hongcai Shang
DOI: https://doi.org/10.3969/j.issn.1673-7202.2017.06.006
2017-01-01
Abstract:New TCM drugs used for certain syndromes are spotlights in the research of Traditional Chinese Medicine (TCM) in recent years.But it is difficult to evaluate the clinical efficacy of these drugs.Developing standardized and unified syndrome names based on literature reviews and expert consultation is important.Then it is necessary to develop acknowledged syndrome diagnosis scales and syndrome evaluation scales to ensure clinical trials objective.It is a decent method to decrease heterogeneity if a core outcome set is developed for syndrome evaluation.Randomized registry trials can be used in screening applicable diseases for New TCM drugs used for certain syndromes,or screening applicable drugs for a syndrome.Randomized controlled trials are the best methods to explore the relation of prescription-syndrome-disease-efficacy critically.N-of-1 trial can be used in the research of prescriptions corresponding to syndromes,and the research of comparing new TCM drugs for certain syndromes with treatment based on syndrome differentiation to explore the rationality of new TCM drugs used for certain syndromes and the significance of syndrome differentiation and treatment.In the end,the benefits of evidence-based goal attainment scales and fuzzy comprehensive evaluation method is combined to develop a comprehensive evaluation method which is based on individualized evaluation and focusing on syndrome efficacy evaluation.
What problem does this paper attempt to address?